Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Cosmos Rx Medication Adherence Platform (FORTISKAP™) vs. Pharmacy Fill Adherence Measures for Subjects Undergoing Treatment for Gastroesophageal Reflux Disease With Proton Pump Inhibitors

NCT07712614 is registered in ClinicalTrials.gov with Cosmos Rx, Inc as lead sponsor.

NCT NCT07712614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07712614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Cosmos Rx Medication Adherence Platform (FORTISKAP™) vs. Pharmacy Fill Adherence Measures for Subjects Undergoing Treatment for Gastroesophageal Reflux Disease With Proton Pump Inhibitors
Lead sponsor
Cosmos Rx, Inc
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
April 1, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gerd (gastroesophageal reflux disease)